Spearheaded the development of the Cell Therapy internal and external long-range network strategy to streamline capacity and incorporate critical drug substance testing internalization. Established an enterprise-wide Operational Excellence organization, implementing standard metrics, tier processes, and programs to reduce costs, enhance compliance, and improve supply reliability.• Implemented a Value Stream Mapping for Internal and External Manufacturing sites, driving standardization, cost reduction, and compliance improvements, leading to a projected savings of approximately $22 million by 2024.• Developed an enterprise-wide centralized portfolio management system and process through GPSiPlan to strategically allocate budget and resources to prioritize projects, reducing the overall project portfolio from over 250 to 10, freeing up resources.• Restructured and implemented a new governance and escalation structure across Cell Therapy for real-time issue escalation and resolution at the appropriate organizational level.• Actively mentored and developed over 10 high-potential leaders within the company and participated as a member of ERG Leadership Teams.

I successfully implemented an end-to-end manufacturing structure to enhance and stabilize throughput time and spearheaded the development and execution of a standardized global manufacturing model for the platform. I also orchestrated the creation and implementation of a comprehensive manufacturing blueprint for the Cell and Gene Platform.● Achieved a 45% increase in productivity in the initial year amidst rising CAR-T demand.● Generated $30MM in productivity gains over 16 months, driving a 70% uptick in production volumes.● Led a team in enhancing manufacturing success rate by approximately 30% over a two-year span.● Successfully decreased platform spending by $45MM within one year.● Directed the implementation of Lean design principles and capability building across the Cell and Gene Platform.● Elevated site engagement score by 8% within a calendar year.

Assigned to establish world-class end-to-end supply chain planning capability, I designed planning techniques supported by enhanced business processes and advanced systems. By balancing supply with demand, I optimize inventory management and support for enterprise growth. I lead and motivate a cross-divisional global team to peak performance levels. DELIVERED RESULTS: ==> By introducing high-impact technical and business processes, I significantly improved planning efficiency and reduced inventory/company discards. ==> My program is on track to achieve net present value (NPV) of $99 million by the end of 2017 with $500 million is inventory reduction, $97 million in discards, and $40 million in improved headcount efficiency. I maximized support capabilities by streamlining end-to-end planning structure and greatly enhancing planning capabilities.

While overseeing bulk distribution, filling, labeling, and packing of vaccine products, I spearheaded component/equipment production and maximized supply chain operations. I redesigned and consolidated factories into one organization and launched lean continuous process improvements. In doing so, I empowered the workforce with the best tools and solutions. I directed a staff of 400+ union/non-union employees and $78 million budget.DELIVERED RESULTS:==> In fewer than 2 years, I brought the operating budget from $78 million to $64 million. ==> By bringing work in-house, I reduced consulting fees from $300,000 to $30,000 per year.==> I slashed annual product deviations from 450 to 170, exceeding 50% reduction target. ==> Without impact to quality or output, I decreased headcount from 350 to 300. ==> I consolidated 7 manufacturing departments into a single, centralized organization

By designing and managing a highly efficient supply chain design for Small Molecule Oncology products, I maximized revenue growth, profitability, and product quality. To enhance all phases of the product lifecycle, I leveraged lean methodologies. I crafted disruptive 5-year strategies that included product master plans. While improving supply chain performance and outcomes, I directed both internal and external operations. I partnered with Research & Development (R&D) Department to ensure new products were filed and launched on time. DELIVERED RESULTS:==> While minimizing working capital and enabling revenue growth, I successfully managed a $1+ billion end-to-end supply chain. ==> I sustained business performance with all key products while driving strategic objectives for future product introductions. To so so, I identified and capitalized on improvement opportunities.==> As the Supply Chain Management Prioritization Program Leader, I seamlessly integrated end-to-end supply chain portfolio to better manage strategic priortities between compliance, supply, and cost. Empowering the division to prioritize critical work by implementing new platform, I led a project team of 5 and streamlined portfolio by 40%. While doing so, I met all deadlines.==> I maintained customer service of 98% line item fill rate (LIFR) across all Tier 1 products.

Greatly improving supply chain and compliance procedures by introducing lean methodologies, I implemented continuous improvements and best practices across 4 sites. I deployed integrated approach throughout all levels of the organization. While steering and mentoring 7 directors and a multi-disciplinary staff of 100, I managed a $17 million budget.DELIVERED RESULTS:==> After devising transformational strategy for vaccine manufacturing site, I supported $4 billion in sales. ==> By employing Six Sigma methods in 4 facilities, I saved $130+ million.==> I slashed costs $12 million by standardizing franchise manufacturing processes.==> Not only did I cut cycle times from 300 days to 200 days, I improved throughput. ==> I reduced human errors/deviations 30% statewide with new, integrated approach.

Led development of transformational strategy for key vaccine manufacturing site that generated $4B in sales. Charged with implementation across 4 sites. Directed 7 Directors and multi-disciplinary staff of 100 and $17M budget.* Gained more than $130M in cost savings; launched Lean Six Sigma resources and revamped supply and compliance procedures.* Improved throughput and cycle times from 300 days to 200 days.* Achieved site-wide 30% reduction in human error deviations.

By instituting extremely effective end-to-end supply chain and global business process standards, I achieved maximum product value. I introduced lean methodologies and change execution management strategies across the manufacturing network. To apply lean enterprise process management across non-manufacturing business processes, I structured a new global framework DELIVERED RESULTS:==> Preventing $200 million in costs, as well as product stock-out, while designing/launching critical franchise product family model, I leveraged value chain management practices.==> To realize $4 million in non-headcount cost reductions, I saved 283 FTE hours, and cut cycle times by 343 days in non-manufacturing areas. ==> I reduced cycle time from 36 to 20 months after implementing SOPs and metric management model for business leaders.

Recruited to drive scalable global implementation of lean operational excellence model for critical business processes, I trained teams to implement and sustain improvements across 27 plants.DELIVERED RESULTS:==> I decreased cycle time 50% and costs 30% while spearheading global inventory improvements

While optimizing quality, safety, profitability and supply chain cycle times, I dramatically improved capabilities of a 100,000+ employee facility. Serving as Value Stream Manager and Lean Leader to boost site productivity, Ianalyzed and deployed Six Sigma methods.DELIVERED RESULTS:==> I cut inventory by $10 million and reduced scrap by $4 million.

Appointed to revitalize blood transfusion franchise, control operating expenses, and act as Value Stream Manager, I oversaw bulk manufacturing, sterile fill, label, pack, and delivery operations. I ensured manufacturing, product development, sales, and marketing priorities aligned with value chain and strategic direction. By producing lean and flexible sales, inventory, and operating plan (SIOP), I achieved all franchise objectives . DELIVERED RESULTS:==> By devising and deftly managing final supply strategies, I maintained 98% LIFR. ==> I expanded organizational capabilities by recruiting/developing highly talented professionals to fill key site leadership roles.==> While directing production, operations, maintenance, and engineering functions, I increased on-time deliveries, lowered expenses, and enhanced product quality.